NCT00437372 2025-05-02Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer PatientsThomas Jefferson UniversityPhase 1 Completed39 enrolled
NCT00381641 2025-03-28Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by SurgeryNational Cancer Institute (NCI)Phase 2 Completed63 enrolled 12 charts